These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 31453713)
1. Insulin resistance takes center stage: a new paradigm in the progression of bipolar disorder. Calkin CV Ann Med; 2019; 51(5-6):281-293. PubMed ID: 31453713 [TBL] [Abstract][Full Text] [Related]
3. Insulin Resistance and Blood-Brain Barrier Dysfunction Underlie Neuroprogression in Bipolar Disorder. Calkin C; McClelland C; Cairns K; Kamintsky L; Friedman A Front Psychiatry; 2021; 12():636174. PubMed ID: 34113269 [TBL] [Abstract][Full Text] [Related]
4. Course of bipolar illness worsens after onset of insulin resistance. Cairns K; McCarvill T; Ruzickova M; Calkin CV J Psychiatr Res; 2018 Jul; 102():34-37. PubMed ID: 29579625 [TBL] [Abstract][Full Text] [Related]
5. Areas of controversy in neuroprogression in bipolar disorder. Passos IC; Mwangi B; Vieta E; Berk M; Kapczinski F Acta Psychiatr Scand; 2016 Aug; 134(2):91-103. PubMed ID: 27097559 [TBL] [Abstract][Full Text] [Related]
6. Inflammation as a Mechanism of Bipolar Disorder Neuroprogression. Barichello T; Giridharan VV; Bhatti G; Sayana P; Doifode T; Macedo D; Quevedo J Curr Top Behav Neurosci; 2021; 48():215-237. PubMed ID: 33040314 [TBL] [Abstract][Full Text] [Related]
7. Neuroprogression and illness trajectories in bipolar disorder. Kapczinski NS; Mwangi B; Cassidy RM; Librenza-Garcia D; Bermudez MB; Kauer-Sant'anna M; Kapczinski F; Passos IC Expert Rev Neurother; 2017 Mar; 17(3):277-285. PubMed ID: 27659841 [TBL] [Abstract][Full Text] [Related]
8. Progression of the functional deficit in a group of patients with bipolar disorder: a cluster analysis based on longitudinal data. López-Villarreal A; Sánchez-Morla EM; Jiménez-López E; Martínez-Vizcaíno V; Aparicio AI; Mateo-Sotos J; Rodriguez-Jimenez R; Vieta E; Santos JL Eur Arch Psychiatry Clin Neurosci; 2020 Dec; 270(8):947-957. PubMed ID: 31422453 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of insulin resistance and its associated factors in drug-naïve patients with bipolar disorder among Han Chinese population. Li K; Li T; Yang T; Lin Y; Liao Y; Gan Z BMC Psychiatry; 2024 May; 24(1):388. PubMed ID: 38783222 [TBL] [Abstract][Full Text] [Related]
10. TNF-α and its soluble receptors mediate the relationship between prior severe mood episodes and cognitive dysfunction in euthymic bipolar disorder. Millett CE; Harder J; Locascio JJ; Shanahan M; Santone G; Fichorova RN; Corrigan A; Baecher-Allan C; Burdick KE Brain Behav Immun; 2020 Aug; 88():403-410. PubMed ID: 32272224 [TBL] [Abstract][Full Text] [Related]
11. Staging and neuroprogression in bipolar disorder. Fries GR; Pfaffenseller B; Stertz L; Paz AV; Dargél AA; Kunz M; Kapczinski F Curr Psychiatry Rep; 2012 Dec; 14(6):667-75. PubMed ID: 23090632 [TBL] [Abstract][Full Text] [Related]
12. Structural and Functional Brain Correlates of Neuroprogression in Bipolar Disorder. Librenza-Garcia D; Suh JS; Watts DP; Ballester PL; Minuzzi L; Kapczinski F; Frey BN Curr Top Behav Neurosci; 2021; 48():197-213. PubMed ID: 33040317 [TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier imaging as a potential biomarker for bipolar disorder progression. Kamintsky L; Cairns KA; Veksler R; Bowen C; Beyea SD; Friedman A; Calkin C Neuroimage Clin; 2020; 26():102049. PubMed ID: 31718955 [TBL] [Abstract][Full Text] [Related]
15. Two-year course of cognitive function and instrumental activities of daily living in older adults with bipolar disorder: evidence for neuroprogression? Gildengers AG; Chisholm D; Butters MA; Anderson SJ; Begley A; Holm M; Rogers JC; Reynolds CF; Mulsant BH Psychol Med; 2013 Apr; 43(4):801-11. PubMed ID: 22846332 [TBL] [Abstract][Full Text] [Related]
16. Insulin resistance in bipolar disorder: A systematic review of illness course and clinical correlates. Miola A; Alvarez-Villalobos NA; Ruiz-Hernandez FG; De Filippis E; Veldic M; Prieto ML; Singh B; Sanchez Ruiz JA; Nunez NA; Resendez MG; Romo-Nava F; McElroy SL; Ozerdem A; Biernacka JM; Frye MA; Cuellar-Barboza AB J Affect Disord; 2023 Aug; 334():1-11. PubMed ID: 37086806 [TBL] [Abstract][Full Text] [Related]
17. Neuroprogression as an Illness Trajectory in Bipolar Disorder: A Selective Review of the Current Literature. Serafini G; Pardini M; Monacelli F; Orso B; Girtler N; Brugnolo A; Amore M; Nobili F; Team On Dementia Of The Irccs Ospedale Policlinico San Martino DM Brain Sci; 2021 Feb; 11(2):. PubMed ID: 33672401 [TBL] [Abstract][Full Text] [Related]
18. Neuropsychological functioning in early and chronic stages of schizophrenia and psychotic bipolar disorder. Menkes MW; Armstrong K; Blackford JU; Heckers S; Woodward ND Schizophr Res; 2019 Apr; 206():413-419. PubMed ID: 31104720 [TBL] [Abstract][Full Text] [Related]
19. [Bipolar disorder: staging and neuroprogression]. Rodrigues AA; Rosa AR; Kunz M; Bruna A; Kapczinski F Psychiatr Pol; 2014; 48(2):231-43. PubMed ID: 25016762 [TBL] [Abstract][Full Text] [Related]
20. Refractory bipolar disorder and neuroprogression. da Costa SC; Passos IC; Lowri C; Soares JC; Kapczinski F Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():103-10. PubMed ID: 26368941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]